RECURRENT LOSS OF FUNCTION OF THE SETD2 GENE IN AGGRESSIVE SYSTEMIC MASTOCYTOSIS AND MAST CELL LEUKEMIA

被引：0
|
作者：
Soverini, S.
Mancini, M.
De Benedittis, C.
Zazzeroni, L.
Papayannidis, C.
Guadagnuolo, V.
Calogero, R.
Zago, E.
Scandola, A.
Garonzi, M.
Savini, P.
Pagano, L.
Zanotti, R.
Perbellini, O.
Bonadonna, P.
Specchia, G.
Merante, S.
Elena, C.
Gangemi, D.
Grifoni, F. I.
Ferrarini, A.
Delledonne, M.
Valent, P.
Cavo, M.
Rondoni, M.
Martinelli, G.
机构：
[1] Univ Bologna, Hematol LeA Seragnoli, Bologna, Italy
[2] Univ Turin, Turin, Italy
[3] Personal Genom Srl, Verona, Italy
[4] Univ Verona, I-37100 Verona, Italy
[5] Osped Infermi, Faenza, Italy
[6] Univ Cattolica S Cuore, Rome, Italy
[7] Hematol Unit, Verona, Italy
[8] Allergy Unit, Verona, Italy
[9] Univ Bari, Bari, Italy
[10] Hematol Unit, Pavia, Italy
[11] Fdn IRCCS Policlin San Matteo, Pavia, Italy
[12] Hematol Unit, Frosinone, Italy
[13] Univ Milan, Dept Hematol, Milan, Italy
[14] Med Univ Vienna, Vienna, Austria
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P140
引用
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [31] NURSING MANAGEMENT WITH AGGRESSIVE SYSTEMIC MASTOCYTOSIS (ASM) AND MAST CELL LEUKEMIA (MCL) PATIENTS: FOCUS ON A NOVEL AGENT MIDOSTAURIN.
    Linder, Andrea
    Gotlib, Jason
    ONCOLOGY NURSING FORUM, 2012, 39 (03) : E220 - E221
  • [32] THE ROLE OF SETD2 MUTATIONS IN PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Yametti, Gloria Contreras
    Narang, Sonali
    Robbins, Gabriel
    Chowdhury, Ashfiyah
    Carroll, William
    Evensen, Nikki
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [33] Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens
    Krauth, M. T.
    Foedinger, M.
    Rebuzzi, L.
    Greul, R.
    Chott, A.
    Valent, P.
    HAEMATOLOGICA, 2007, 92 (12) : E126 - E129
  • [34] The effect of loss of SETD2 on mitochondria! dysfunction in clear cell renal cell carcinoma.
    Hapke, Robert
    Beckermann, Katy
    Rathmell, Kimryn
    Haake, Scott Mattox
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [35] The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)
    Valent, Peter
    Arock, Michel
    Akin, Cem
    Sperr, Wolfgang R.
    Reiter, Andreas
    Sotlar, Karl
    Hartmann, Karin
    George, Tracy I.
    Brockow, Knut
    Kluin-Nelemans, Hanneke C.
    Gotlib, Jason
    Metcalfe, Dean D.
    Horny, Hans-Peter
    BLOOD, 2010, 116 (05) : 850 - 851
  • [36] SETD2 LOSS CONTRIBUTES TO CHRONIC MYELOID LEUKEMIA PROGRESSION AFFECTING DNA INTEGRITY AND EPIGENETIC LANDSCAPE
    Mancini, M.
    De Santis, S.
    Monaldi, C.
    Bruno, S.
    Taccini, A. C.
    Castagnetti, F.
    Gugliotta, G.
    Iurlo, A.
    Cerrano, M.
    Galimberti, S.
    Balducci, S.
    Cavo, M.
    Soverini, S.
    HAEMATOLOGICA, 2024, 109 : 67 - 67
  • [37] SETD2 Heterozygous Loss in Leukemia Leads to Chemotherapy Resistance through Attenuation of the DNA Damage Response
    Mar, Brenton G.
    Kahn, Josephine
    Zon, Rebecca L.
    Grauman, Peter V.
    Boettger, Kevin
    Chu, Scott Haihua
    Armstrong, Scott A.
    Ebert, Benjamin L.
    BLOOD, 2015, 126 (23)
  • [38] SETD2 Loss Contributes to Chronic Myeloid Leukemia Progression Affecting DNA Integrity and Epigenetic Landscape
    Mancini, Manuela
    De Santis, Sara
    Monaldi, Cecilia
    Bruno, Samantha
    Mosca, Cristina
    Romagnoli, Lucia
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Iurlo, Alessandra
    Cerrano, Marco
    Galimberti, Sara
    Balducci, Serena
    Cavo, Michele
    Soverini, Simona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S366 - S367
  • [39] Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia
    Oh, Stephen T.
    Miller, Christopher A.
    Gindin, Yevgeniy
    Brost, Taylor M.
    Chan, Jason
    Fulbright, Mary C.
    Fisher, Daniel A. C.
    Duncavage, Eric J.
    O'Laughlin, Michelle
    Griffith, Malachi
    Griffith, Obi L.
    Wartman, Lukas D.
    BLOOD, 2016, 128 (22)
  • [40] LOSS OF FUNCTION OF THE SETD2 TUMOR SUPPRESSOR IS A RECURRENT EVENT IN ADVANCED-PHASE CHRONIC MYELOID LEUKEMIA, IS DUE TO POST-TRANSLATIONAL MECHANISMS AND FOSTERS GENETIC INSTABILITY
    Mancini, M.
    De Santis, S.
    Monaldi, Cecilia
    Bavaro, L.
    Martelli, M.
    Castagnetti, F.
    Gugliotta, G.
    Rosti, G.
    Iurlo, A.
    Abruzzese, E.
    Salvucci, M.
    Pregno, P.
    Gozzini, A.
    Crugnola, M.
    Albano, F.
    Bonifacio, M.
    Calistri, E.
    Tiribelli, M.
    Binotto, G.
    Imovilli, A.
    Trabacchi, E.
    Galimberti, S.
    Barate, C.
    Tenti, E.
    Baccarani, M.
    Cavo, M.
    Martinelli, G.
    Soverini, S.
    HAEMATOLOGICA, 2018, 103 : S47 - S47
12345